In asthma and airway remodeling, cytokines can directly modulate myocyte function by amplifying and perpetuating inflammatory responses, and by inducing airway smooth muscle (ASM) growth. Although many studies have identified mechanisms that regulate inflammatory cell trafficking and activation in asthma, few have asserted a role for myocytes in modulating airway inflammation and none examined the critical signaling pathways that regulate ASM synthetic functions. The goal of this proposal is to define the cellular and molecular signaling processes that regulate cytokine-induced synthetic functions (defined as cell adhesion molecule (CAM) expression, and cytokine, chemokine, and autocrine growth factor secretion) in human ASM. Recent studies by the P.I.'s laboratory support the role of IL-1beta and TNF-alpha in modulating synthetic functions in ASM. Preliminary data from this proposal now demonstrate that IL-beta and TNF-alpha activate NF-kappaB, sphingomyelinase (SMase), and mitogen-activated protein kinase (MAPK) pathways in ASM, and that selective inhibition of these pathways has differential effects on the modulation of synthetic functions by cytokines. Collectively, these findings support a central hypothesis that pro-inflammatory cytokines regulate CAM expression and cytokine, chemokine, and growth factor secretion through coordinate activation of NF-kappaB, SMase, and MAPK pathways. Recently established techniques for the transfection and microinjection of human ASM cells will enable delineation of the precise molecular mechanisms by which cytokines activate these pathways and regulate synthetic functions.
In Aim 1, the role of NF-kappaB will be explored by inhibiting or activating NF-kappaB through the use of dominant negative and constitutively active cDNA constructs and assessing attendant alterations in CAM expression, cytokine and autocrine growth factor secretion in cells stimulated with pro-inflammatory cytokines.
In Aim 2, the role of cytokine-induced sphingolipid generation in modulating synthetic functions will be investigated by characterizing the products of SMase in response to cytokine stimulation. In addition, direct stimulation or inhibition of SMase will be achieved via transfection or microinjection techniques to determine whether SMase activity is required or sufficient to mediate changes in ASM synthetic functions.
In Aim 3, the role of MAPK in modulating cytokine regulation of synthetic functions will be examined. Activation of the p42/p44, JNK, and p38 pathways will be assessed using both immunoblot analysis and in vitro kinase assays. Selective inhibition of the MAPK pathways using molecular and pharmacological means will help establish the requirement/sufficiency of a given MAPK pathway in promoting cytokine effects on ASM synthetic functions. Achievement of these aims will significantly advance our understanding of the pathogenesis of asthma and airway remodeling. By understanding the mechanisms by which ASM synthetic responses are regulated, new issues in the pathogenesis of asthma will be addressed and therapeutic measures to prevent these alterations can be developed.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL064063-02
Application #
6184453
Study Section
Special Emphasis Panel (ZHL1-CSR-Q (S1))
Project Start
1999-09-30
Project End
2003-08-31
Budget Start
2000-09-01
Budget End
2001-08-31
Support Year
2
Fiscal Year
2000
Total Cost
$335,697
Indirect Cost
Name
University of Pennsylvania
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Bhandare, Reena; Damera, Gautam; Banerjee, Audreesh et al. (2010) Glucocorticoid receptor interacting protein-1 restores glucocorticoid responsiveness in steroid-resistant airway structural cells. Am J Respir Cell Mol Biol 42:9-15
Amrani, Yassine; Syed, Farhat; Huang, Chris et al. (2010) Expression and activation of the oxytocin receptor in airway smooth muscle cells: Regulation by TNFalpha and IL-13. Respir Res 11:104
Goncharova, Elena A; Goncharov, Dmitry A; Damera, Gautam et al. (2009) Signal transducer and activator of transcription 3 is required for abnormal proliferation and survival of TSC2-deficient cells: relevance to pulmonary lymphangioleiomyomatosis. Mol Pharmacol 76:766-77
Panettieri Jr, Reynold A (2009) Asthma persistence versus progression: does airway smooth muscle function predict irreversible airflow obstruction? Allergy Asthma Proc 30:103-8
Tliba, Omar; Panettieri Jr, Reynold A (2009) Noncontractile functions of airway smooth muscle cells in asthma. Annu Rev Physiol 71:509-35
Damera, Gautam; Tliba, Omar; Panettieri Jr, Reynold A (2009) Airway smooth muscle as an immunomodulatory cell. Pulm Pharmacol Ther 22:353-9
Jain, Deepika; Keslacy, Stefan; Tliba, Omar et al. (2008) Essential role of IFNbeta and CD38 in TNFalpha-induced airway smooth muscle hyper-responsiveness. Immunobiology 213:499-509
Tliba, Omar; Damera, Gautam; Banerjee, Audreesh et al. (2008) Cytokines induce an early steroid resistance in airway smooth muscle cells: novel role of interferon regulatory factor-1. Am J Respir Cell Mol Biol 38:463-72
Tliba, Omar; Amrani, Yassine (2008) Airway smooth muscle cell as an inflammatory cell: lessons learned from interferon signaling pathways. Proc Am Thorac Soc 5:106-12
Goncharova, Elena A; Goncharov, Dmitry A; Chisolm, Amelia et al. (2008) Interferon beta augments tuberous sclerosis complex 2 (TSC2)-dependent inhibition of TSC2-null ELT3 and human lymphangioleiomyomatosis-derived cell proliferation. Mol Pharmacol 73:778-88

Showing the most recent 10 out of 46 publications